These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25795452)

  • 1. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.
    Bhatt AB; Buck JS; Zuflacht JP; Milian J; Kadivar S; Gauvreau K; Singh MN; Creager MA
    Vasc Med; 2015 Aug; 20(4):317-25. PubMed ID: 25795452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
    Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
    Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correspondence regarding: Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome by Bhatt et al.
    O'Rourke MF; Adji A; Weber T
    Vasc Med; 2016 Feb; 21(1):70. PubMed ID: 26669325
    [No Abstract]   [Full Text] [Related]  

  • 4. Atenolol versus losartan in children and young adults with Marfan's syndrome.
    Lacro RV; Dietz HC; Sleeper LA; Yetman AT; Bradley TJ; Colan SD; Pearson GD; Selamet Tierney ES; Levine JC; Atz AM; Benson DW; Braverman AC; Chen S; De Backer J; Gelb BD; Grossfeld PD; Klein GL; Lai WW; Liou A; Loeys BL; Markham LW; Olson AK; Paridon SM; Pemberton VL; Pierpont ME; Pyeritz RE; Radojewski E; Roman MJ; Sharkey AM; Stylianou MP; Wechsler SB; Young LT; Mahony L;
    N Engl J Med; 2014 Nov; 371(22):2061-71. PubMed ID: 25405392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.
    Forteza A; Evangelista A; Sánchez V; Teixidó-Turà G; Sanz P; Gutiérrez L; Gracia T; Centeno J; Rodríguez-Palomares J; Rufilanchas JJ; Cortina J; Ferreira-González I; García-Dorado D
    Eur Heart J; 2016 Mar; 37(12):978-85. PubMed ID: 26518245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.
    Teixido-Tura G; Forteza A; Rodríguez-Palomares J; González Mirelis J; Gutiérrez L; Sánchez V; Ibáñez B; García-Dorado D; Evangelista A
    J Am Coll Cardiol; 2018 Oct; 72(14):1613-1618. PubMed ID: 30261963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol.
    Hwang JW; Kim EK; Jang SY; Chung TY; Ki CS; Sung K; Kim SM; Ahn J; Carriere K; Choe YH; Chang SA; Kim DK
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):743-749. PubMed ID: 29198406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
    Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
    Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of losartan and metoprolol on left ventricular and aortic function at rest and during exercise in chronic aortic regurgitation.
    Roberts PA; Lin ACW; Cowan BR; Young AA; Stewart R
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):615-624. PubMed ID: 29119275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
    Georgianos PI; Agarwal R
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):639-45. PubMed ID: 25784174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol versus Losartan in Marfan's Syndrome.
    Lacro RV; Dietz HC; Mahony L
    N Engl J Med; 2015 Mar; 372(10):980-1. PubMed ID: 25738680
    [No Abstract]   [Full Text] [Related]  

  • 12. Atenolol versus Losartan in Marfan's Syndrome.
    Ziganshin BA; Mukherjee SK; Elefteriades JA
    N Engl J Med; 2015 Mar; 372(10):977-8. PubMed ID: 25738681
    [No Abstract]   [Full Text] [Related]  

  • 13. Atenolol versus Losartan in Marfan's Syndrome.
    Treasure T; Pepper J; Mohiaddin R
    N Engl J Med; 2015 Mar; 372(10):978-9. PubMed ID: 25738682
    [No Abstract]   [Full Text] [Related]  

  • 14. Atenolol versus Losartan in Marfan's Syndrome.
    Mallat Z; Tedgui A
    N Engl J Med; 2015 Mar; 372(10):980. PubMed ID: 25738683
    [No Abstract]   [Full Text] [Related]  

  • 15. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial.
    Radonic T; de Witte P; Baars MJ; Zwinderman AH; Mulder BJ; Groenink M;
    Trials; 2010 Jan; 11():3. PubMed ID: 20067609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers.
    Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J
    Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
    Lacro RV; Dietz HC; Wruck LM; Bradley TJ; Colan SD; Devereux RB; Klein GL; Li JS; Minich LL; Paridon SM; Pearson GD; Printz BF; Pyeritz RE; Radojewski E; Roman MJ; Saul JP; Stylianou MP; Mahony L;
    Am Heart J; 2007 Oct; 154(4):624-31. PubMed ID: 17892982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.
    Van Driest SL; Sleeper LA; Gelb BD; Morris SA; Dietz HC; Forbus GA; Goldmuntz E; Hoskoppal A; James J; Lee TM; Levine JC; Li JS; Loeys BL; Markham LW; Meester JAN; Mital S; Mosley JD; Olson AK; Renard M; Shaffer CM; Sharkey A; Young L; Lacro RV; Roden DM
    J Pediatr; 2020 Jul; 222():213-220.e5. PubMed ID: 32586526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].
    Forteza A; Evangelista A; Sánchez V; Teixidó G; García D; Sanz P; Gutiérrez L; Centeno J; Rodríguez-Palomares J; Cortina J; García-Dorado D
    Rev Esp Cardiol; 2011 Jun; 64(6):492-8. PubMed ID: 21561700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
    Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA
    JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.